Freeline Therapeutics Holdings plc Accumulated Other Comprehensive Income
Freeline Therapeutics Holdings plc had Accumulated Other Comprehensive Income of -$1.57 million as of 2023-09-30, per its 6-K filed 2023-12-01.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2023-12-01
- 2023-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$1.57M.
- 2023-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$784.00K.
- 2023-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$1.72M.
- 2022-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$3.15M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2023-09-30 | -$1.57M 6-K · filed 2023-12-01 |
| 2023-06-30 | -$784.00K 6-K · filed 2023-08-15 |
| 2023-03-31 | -$1.72M 6-K · filed 2023-05-30 |
| 2022-12-31 | -$3.15M 6-K · filed 2023-12-01 |
| 2022-09-30 | -$8.85M 6-K · filed 2022-11-15 |
| 2022-06-30 | -$1.50M 6-K · filed 2022-08-09 |
| 2022-03-31 | $6.74M 6-K · filed 2022-05-10 |
| 2021-12-31 | $9.47M 20-F · filed 2023-04-04 |
| 2021-09-30 | $9.06M 6-K · filed 2021-11-09 |
| 2021-06-30 | $14.20M 6-K · filed 2021-08-16 |
| 2021-03-31 | $11.37M 6-K · filed 2021-05-17 |
| 2020-12-31 | $9.34M 20-F · filed 2022-03-31 |
| 2020-06-30 | -$7.17M 6-K · filed 2020-10-29 |
| 2019-12-31 | -$3.00M 20-F · filed 2021-03-31 |